The new challenges that arose in the wake of the Covid-19 pandemic gave rise to a large number of cross-industry and cross-enterprise collaborations among organizations in the pharma industry. As collaborative approaches become the key to tackle the global hardship, pharma marketers invest more time in promoting their organizations more attractively among B2B spaces. Concurrently with large pharma organizations, contract development and manufacturing organizations are focusing on reinforcing ties with colleagues as well as competitors for better efficiencies and to branch out globally where outsourcing services and production will be extremely crucial.
As technological innovations positively impact not just drug development but other critical aspects of the drug supply chain in the form of safety, manpower, and time, CDMOs are acquiring AI and other robotics to reap the benefits. The shortened production cycles, more efficient processes, and lower production costs will offer pharma marketers unique selling propositions to help increase the number of collaborative ventures.
Staying abreast of all the latest developments, Pharma Tech Outlook has shortlisted the most promising pharma marketing solution providers. A distinguished panel comprising prominent CEOs, CIOs, VCs, analysts, and the editorial board of Pharma Tech Outlook has compiled a list of services and consulting companies that are at the forefront of deploying advanced pharma marketing offerings to assist organizations in the competitive long run.
We present to you “Top 10 Pharma Marketing Companies in Europe – 2021.”
